Hespimin

Hespimin is an oral flavonoid venous vasoprotective containing the active ingredient diosmin. It is marketed in the European Union as an over‑the‑counter product for chronic venous and hemorrhoidal conditions. The formulation provides diosmin in a tablet (strength not disclosed) and is intended to support normal venous tone and microcirculatory health. It is classified under ATC code C05CA03 and belongs to the flavonoid class with antioxidant and anti‑inflammatory properties.

Hespimin is used to manage several conditions related to impaired venous circulation and hemorrhoidal discomfort.

- Chronic venous insufficiency (CVI) to relieve leg heaviness, swelling, and aching. - Varicose veins to reduce edema and improve vein elasticity. - Hemorrhoidal disease to alleviate bleeding, pain, and itching. - Post‑thrombotic syndrome to support microvascular recovery. - Prevention of recurrent venous symptoms after surgical or sclerotherapy procedures.

Adverse reactions to Hespimin are generally mild, but rare serious events have been reported.

Common: - Gastrointestinal discomfort such as nausea, abdominal pain, or dyspepsia. - Headache or dizziness. - Mild skin rash or pruritus. - Flushing or warmth sensation. - Palpitations or transient tachycardia.

Serious: - Severe allergic reactions including angioedema or anaphylaxis. - Hepatic enzyme elevation indicating possible liver injury. - Thrombotic events in predisposed individuals (very rare). - Hemorrhagic complications in patients with bleeding disorders. - Significant hypotension or hypertension.

When considering Hespimin, certain precautionary measures should be observed to minimize risk.

- Do not use if you have a known hypersensitivity to diosmin or related flavonoids. - Use with caution in individuals with liver disease or elevated hepatic enzymes. - Avoid in patients with active bleeding or clotting disorders. - Monitor blood pressure if you have hypertension. - Consider renal function in elderly patients. - Discuss with a healthcare provider before use during pregnancy or lactation. - Review concomitant use of anticoagulants or antiplatelet agents.

Hespimin may affect the activity of other medicines; awareness of potential interactions helps ensure safe use.

Avoid: - Concurrent use with strong anticoagulants such as warfarin or direct oral anticoagulants, which may increase bleeding risk. - Combination with high‑dose NSAIDs that can exacerbate gastrointestinal irritation.

Use with caution: - Co‑administration with other flavonoid supplements that could potentiate vasoprotective effects. - Use alongside antihypertensive agents, as diosmin may modestly lower blood pressure. - Interaction with cytochrome P450 substrates, particularly CYP3A4, may alter drug levels.